University of Michigan Rogel Cancer Center: Squamous Cell Carcinoma of Head and Neck trials

The registry lists 10 Squamous Cell Carcinoma of Head and Neck studies with University of Michigan Rogel Cancer Center as lead sponsor. 2 are open to participants now and 6 have results posted.

Phase 2 9No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialRecruitingNCT07121595Phase 2
• A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)RecruitingNCT05894083Phase 2
• Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck CancerCompletedNCT03829722Phase 2Results posted
• Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT03194373Phase 2Results posted
• Expansion Trial for Axitinib In Head And Neck CancerCompletedNCT02762513Phase 2Results posted
• Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck CancerCompletedNCT02031250Phase 2Results posted
• Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck CancerCompletedNCT01469546Phase 2Results posted
• A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and NeckTerminatedNCT01285635Phase 2Results posted
• A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell CarcinomaWithdrawnNCT02649530Phase 2
• Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive TherapyCompletedNCT01794481Not applicable